Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
WallSt.WatchdogMore than just a barking dog. We dig deep, sniff out scams, and expose market manipulations. Join us to become a savvier investor, armed with truth and insight. Remember, Wall Street might sleep, but the Watchdog never does.
05 Jun 2025$RSLS dropped over 37% in three days, surprising given its recent EU Medical Device Regulation (MDR) certification, a bullish catalyst for growth in Europe and the UK. Despite the pullback, RSLS remains in an uptrend with neutral RSI and trading above key moving averages.
The drop seems tied to profit-taking and low trading volume rather than deteriorating fundamentals. For traders focused on short-term rebound stocks, RSLS offers a compelling risk/reward setup if volume returns and the market digests the regulatory news.
$IMNN fell about 27% amid broader biotech sell-offs despite positive Phase 2 clinical data on ovarian cancer survival presented at ASCO. The stock’s neutral RSI and ongoing uptrend suggest consolidation, with a bounce likely if biotech sector sentiment improves.
Given its high beta and lower trading volume, IMNN is a volatile but interesting candidate for traders looking to capitalize on biotech rebounds following significant clinical news.
$ASAN declined 22.5%, pressured by mixed Q1 earnings and cautious guidance, along with a drop below its 200-day moving average, a key technical support level. The stock’s RSI nears oversold, but heavy selling volume and analyst downgrades highlight risk.
For traders prioritizing low-risk bounce plays, ASAN appears less attractive short term, with sideways trends and bearish signals outweighing potential upside.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
